142 related articles for article (PubMed ID: 36403750)
1. Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlands.
Vermariën-Wang J; Doeleman T; van Doorn R; Mooyaart AL; Blokx WAM; Schrader AMR
J Am Acad Dermatol; 2023 Mar; 88(3):602-608. PubMed ID: 36403750
[TBL] [Abstract][Full Text] [Related]
2. Theory and practical application of superficial atypical melanocytic proliferations of uncertain significance (SAMPUS) and melanocytic tumours of uncertain malignant potential (MELTUMP) terminology: experience with second opinion consultation.
Pusiol T; Morichetti D; Piscioli F; Zorzi MG
Pathologica; 2012 Apr; 104(2):70-7. PubMed ID: 22953503
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features, Dermoscopic Patterns, and Histological Diagnostic Model for Melanocytic Tumors of Uncertain Malignant Potential (MELTUMP).
Pusiol T; Piscioli F; Speziali L; Zorzi MG; Morichetti D; Roncati L
Acta Dermatovenerol Croat; 2015; 23(3):185-94. PubMed ID: 26476902
[TBL] [Abstract][Full Text] [Related]
4. SAMPUS, MELTUMP and THIMUMP - Diagnostic Categories Characterized by Uncertain Biological Behavior.
Roncati L; Piscioli F; Pusiol T
Klin Onkol; 2017; 30(3):221-223. PubMed ID: 28612620
[TBL] [Abstract][Full Text] [Related]
5. Performance of PRAME immunohistochemistry compared with that of c-Kit, c-Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors.
Jung JM; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
Pathol Int; 2023 Jan; 73(1):27-36. PubMed ID: 36468840
[TBL] [Abstract][Full Text] [Related]
6. MELTUMP: how to manage these lesions in the clinical routine.
Piccolo V; Moscarella E; Lallas A; Alfano R; Ferrara G; Argenziano G
G Ital Dermatol Venereol; 2017 Jun; 152(3):266-269. PubMed ID: 28195450
[TBL] [Abstract][Full Text] [Related]
7. [Melanocytic tumour of uncertain malignant potential; practical dilemmas].
Rozendaal AM; de Haas ERM; Mooi W; de Roos KP
Ned Tijdschr Geneeskd; 2019 Jul; 163():. PubMed ID: 31283126
[TBL] [Abstract][Full Text] [Related]
8. The approach to the patient with a difficult melanocytic lesion.
Elder DE; Xu X
Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
Lee JJ; Vilain RE; Granter SR; Hu NR; Bresler SC; Xu S; Frank AH; Mihm MC; Saw RP; Fletcher CD; Scolyer RA; Murphy GF; Lian CG
J Cutan Pathol; 2017 Mar; 44(3):249-255. PubMed ID: 28032662
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic invasion predicts aggressive behavior in melanocytic tumors of uncertain malignant potential (MELTUMP).
Abraham RM; Karakousis G; Acs G; Ziober AF; Cerroni L; Mihm MC; Elder DE; Xu X
Am J Surg Pathol; 2013 May; 37(5):669-75. PubMed ID: 23552384
[TBL] [Abstract][Full Text] [Related]
11. Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from The Netherlands.
Zaal LH; Mooi WJ; Klip H; van der Horst CM
Plast Reconstr Surg; 2005 Dec; 116(7):1902-9. PubMed ID: 16327602
[TBL] [Abstract][Full Text] [Related]
12. Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008.
Cerroni L; Barnhill R; Elder D; Gottlieb G; Heenan P; Kutzner H; LeBoit PE; Mihm M; Rosai J; Kerl H
Am J Surg Pathol; 2010 Mar; 34(3):314-26. PubMed ID: 20118771
[TBL] [Abstract][Full Text] [Related]
13. Highlighting the immunohistochemical profile of melanocytomas: review.
Quatresooz P; Piérard-Franchimont C; Piérard GE
Oncol Rep; 2008 Jun; 19(6):1367-72. PubMed ID: 18497938
[TBL] [Abstract][Full Text] [Related]
14. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
15. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
16. Atypical melanocytic lesions: a historical overview.
Manchi M; Canzonieri V
Pol J Pathol; 2019; 70(1):26-32. PubMed ID: 31556548
[TBL] [Abstract][Full Text] [Related]
17. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization analysis of atypical melanocytic proliferations and melanoma in young patients.
DeMarchis EH; Swetter SM; Jennings CD; Kim J
Pediatr Dermatol; 2014; 31(5):561-9. PubMed ID: 24924836
[TBL] [Abstract][Full Text] [Related]
19. PRAME Immunoexpression in 275 Cutaneous Melanocytic Lesions: A Double Institutional Experience.
Cazzato G; Cascardi E; Colagrande A; Belsito V; Lospalluti L; Foti C; Arezzo F; Dellino M; Casatta N; Lupo C; Buongiorno L; Stellacci A; Marrone M; Ingravallo G; Maiorano E; Resta L
Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140597
[TBL] [Abstract][Full Text] [Related]
20. The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential.
Muhlbauer A; Momtahen S; Mihm MC; Wang J; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():30-36. PubMed ID: 28648937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
